Related Experiment Video
Updated: May 16, 2026

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
Elevated serum bone morphogenetic protein 4 in patients with chronic kidney disease and coronary artery disease
Paul F Stahls1, Daniel J Lightell, Stephanie C Moss
1Department of Cardiology, Ochsner Clinic Foundation, New Orleans, LA 70121, USA.
Insights
Elevated levels of serum bone morphogenetic protein-4 (sBMP-4) are linked to both chronic kidney disease (CKD) and coronary artery disease (CAD). Higher sBMP-4 also correlates with coronary artery calcification in these patients.
Area of Science:
- Nephrology
- Cardiology
- Biochemistry
Background:
- Chronic kidney disease (CKD) significantly increases the risk of coronary artery disease (CAD) and coronary artery calcification.
- The underlying mechanisms linking CKD and CAD remain incompletely understood.
- Osteogenic factors are implicated in vascular calcification.
Purpose of the Study:
- To investigate the association between serum bone morphogenetic protein-4 (sBMP-4) and the co-occurrence of CKD and CAD.
- To determine if sBMP-4 levels correlate with the extent of coronary artery calcification (CAC).
Main Methods:
- Serum samples were collected from 79 patients undergoing diagnostic angiography.
- Patients were stratified based on the presence or absence of CKD and CAD.
- Serum sBMP-4 levels were measured and correlated with disease status and CAC scores in a subset of 22 patients.
Main Results:
- Subjects with both CKD and CAD exhibited significantly higher sBMP-4 levels compared to those with only one condition or neither.
- sBMP-4 remained associated with the presence of both CKD and CAD after adjusting for other cardiovascular risk factors.
- A positive correlation was observed between sBMP-4 levels and coronary artery calcium (CAC) scores.
Conclusions:
- Serum sBMP-4 is elevated in patients with comorbid CKD and CAD.
- sBMP-4 levels positively correlate with the burden of coronary artery calcification.
- These findings suggest a potential role for sBMP-4 in the heightened cardiovascular risk associated with CKD.
Abstract:
Chronic kidney disease (CKD) is associated with increased coronary artery disease (CAD) and coronary artery calcification. We hypothesized that the osteogenic factor, bone morphogenetic protein-4 (sBMP-4), is elevated in subjects with both CKD and CAD. Serum was collected from 79 subjects undergoing diagnostic angiography and stratified according to CAD and CKD status. Subjects with both CAD and CKD had significantly elevated sBMP-4 compared to those with only one or no disease. sBMP-4 continued to be associated with the presence of both diseases after adjustment for other risk factors. To determine if sBMP-4 is associated with coronary artery calcification, we compared coronary artery calcium scores (CAC) to sBMP-4 in 22 subjects. A positive correlation between CAC and sBMP-4 was seen. In conclusion, sBMP-4 is elevated in patients with both CAD and CKD and positively correlates with CAC, suggesting a role for sBMP-4 in the increased CAD seen in CKD patients.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Bone Remodeling
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Osteoclasts in Bone Remodeling
Serum Studies: Renal Function Tests
Chronic Kidney Disease III: Interprofessional Care
